These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17082013)

  • 1. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era.
    Li Y; Zhang X; Zou Z; Xiong Y; Gu X; Zou R; Tan J; Zhang L; Zheng Y; Niu T
    Clin Exp Med; 2024 Sep; 24(1):215. PubMed ID: 39249542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review.
    Zhang Y; Pan J; Kang H; Peng S; Tung TH; Shen B
    Ann Med; 2024 Dec; 56(1):2380301. PubMed ID: 39034813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT.
    Waszczuk-Gajda A; Gras L; de Wreede LC; Sirait T; Illes A; Ozkurt ZN; Snowden JA; Arat M; Bulabois CE; Niederland J; Sever M; Paneesha S; Potter V; Gadisseur A; Chalopin T; Van Gorkom G; López JM; Kerre T; Drozd-Sokolowska J; Raj K; Hayden PJ; Beksac M; Yakoub-Agha I; McLornan DP; Schönland S
    Bone Marrow Transplant; 2023 Apr; 58(4):424-429. PubMed ID: 36681775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma.
    Abudayyeh A; Lin H; Mamlouk O; Abdelrahim M; Saliba R; Rondon G; Martinez CS; Delgado R; Page V; Rajasekaran A; Sanders PW; Qazilbash M
    Leuk Lymphoma; 2020 Dec; 61(13):3101-3111. PubMed ID: 32723196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Stem Cell Transplantation in Multiple Myeloma with Renal Failure: Friend or Foe?
    Zhong H; Xie X; Xu G
    Stem Cells Int; 2019; 2019():9401717. PubMed ID: 31781250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
    Antlanger M; Dust T; Reiter T; Böhm A; Lamm WW; Gornicec M; Willenbacher E; Nachbaur D; Weger R; Rabitsch W; Rasoul-Rockenschaub S; Worel N; Lechner D; Greinix H; Keil F; Gisslinger H; Agis H; Krauth MT
    BMC Cancer; 2018 Oct; 18(1):1008. PubMed ID: 30342509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis.
    Mahindra A; Hari P; Fraser R; Fei M; Huang J; Berdeja J; Callander N; Costa L; Diaz MA; Freytes C; Gale RP; Girnius S; Holmberg L; Kharfan-Dabaja M; Kumar S; Kyle R; Lazarus H; Lee C; Maiolino A; Moreb J; Nishihori T; Pawarode A; Saad A; Savani BN; Schriber J; William B; Wirk BM; Krishnan A; Nieto Y; D'Souza A
    Bone Marrow Transplant; 2017 Dec; 52(12):1616-1622. PubMed ID: 28920949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Trends of Renal Impairment in Multiple Myeloma.
    Yadav P; Cook M; Cockwell P
    Kidney Dis (Basel); 2016 Mar; 1(4):241-57. PubMed ID: 27536684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.
    El Fakih R; Fox P; Popat U; Nieto Y; Shah N; Parmar S; Oran B; Ciurea S; Kebriaei P; Hosing C; Ahmed S; Shah J; Orlowski R; Champlin R; Qazilbash M; Bashir Q
    Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):472-6. PubMed ID: 25963284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure.
    Breitkreutz I; Heiss C; Perne A; Beimler J; Jäger D; Egerer G; Ho AD; Neben K; Zeier M; Goldschmidt H; Raab MS
    Bone Marrow Transplant; 2014 Nov; 49(11):1371-5. PubMed ID: 25089594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifty years of melphalan use in hematopoietic stem cell transplantation.
    Bayraktar UD; Bashir Q; Qazilbash M; Champlin RE; Ciurea SO
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):344-56. PubMed ID: 22922522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.
    Lee CK; Zangari M; Barlogie B; Fassas A; van Rhee F; Thertulien R; Talamo G; Muwalla F; Anaissie E; Hollmig K; Tricot G
    Bone Marrow Transplant; 2004 Apr; 33(8):823-8. PubMed ID: 14767499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure.
    Knudsen LM; Nielsen B; Gimsing P; Geisler C
    Eur J Haematol; 2005 Jul; 75(1):27-33. PubMed ID: 15946307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
    Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
    Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma in end-stage renal disease.
    Penfield JG
    Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
    Raab MS; Breitkreutz I; Hundemer M; Benner A; Klaus J; Hegenbart U; Moehler T; Ho AD; Zeier M; Goldschmidt H
    Haematologica; 2006 Nov; 91(11):1555-8. PubMed ID: 17082013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure.
    Tauro S; Clark FJ; Duncan N; Lipkin G; Richards N; Mahendra P
    Bone Marrow Transplant; 2002 Oct; 30(7):471-3. PubMed ID: 12368962
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.